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Although great strides have been made in the treatment and prevention of the human 
immunodeficiency virus (HIV), HIV remains prevalent in the United States. An estimated 1.1 
million people are currently infected with HIV in the U.S.,1 and 50,000 new infections are 
estimated to occur each year.2 Although HIV is typically associated with large urban areas, an 
increasing number of cases are occurring in the rural South.3,4,5 The Centers for Disease Control 
(CDC) estimated that as of 2013, 839 adults and adolescents were diagnosed with HIV in 
Tennessee, ranking it 15th among all 50 states. Tennessee’s HIV population was 63.3% black, 
while whites and Hispanic/Latin Americans made up 31% and 4.6% of the population 
respectively.6 
Modes of Transmission 
HIV is transmitted in a variety of ways through the body fluids of persons infected with 
HIV, including blood, semen, pre-seminal fluids, rectal fluids, vaginal fluids, and breast milk.7 
The most common modes of transmission include men who have sex with men (MSM), 
intravenous drug use (IDU), heterosexual contact (HET), and perinatal contact. MSM constitute 
an estimated 63% of cases in the U.S.8 and 68.9% of cases in Tennessee.6 In rural areas, MSM 
face a number of challenges, such as stigmatization and discrimination,9,10 which may lead to 
adoption of risky sexual behavior as a coping mechanism to mediate psychological stress.11 Such 
behavior would further enhance risk of HIV for rural residents in the MSM population.  
 Aside from MSM transmission, substance use is also a risk factor for HIV infections, as it 
increases the likelihood of high-risk sex with HIV-infected partners.12 Intravenous drug users 
(IDUs) have a particularly high risk to acquire HIV.8 Because HIV is a blood-borne pathogen, 
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people who inject drugs and are diagnosed with HIV can transmit the virus to other individuals if 
they share the same needle that was exposed to HIV-infected blood and not properly sterilized. 
Among rural Appalachians, injection drug users rapidly progress from their first illicit drug use 
to the first injection drug use, with a median time of just three years.7 Of injected drugs, synthetic 
opioids like oxycodone are quite prominent.13 Rural populations have shown to be at risk for 
rapid incidence of HIV from IDU transmission. In 2015, 135 cases of HIV infection were 
reported in a community outbreak in Indiana, and 80% of those infected reported IDU. A high 
portion of those infected were adults who did not complete high school (21.3%) and were living 
in poverty (19.0%).14 Although IDUs are only estimated to account for 2.9% of HIV 
transmission in Tennessee,6 rapid transmission of HIV like that evidenced in Indiana is possible 
for the state, as Tennessee ranks highest for painkiller prescriptions per capita among all states 
(143 prescriptions per 100 persons).15  
 While MSM and IDU are the most prevalent modes of transmission, a number of other 
modes of HIV transmission also occur, including heterosexual contact and perinatal exposure. 
HIV can also be spread through vaginal, oral, and anal sex. Furthermore, HIV transmission can 
occur from an HIV-infected mother to infant in a number of manners, including childbirth.7 
HIV in the South  
Those living in the South are at greater risk of HIV mortality than other areas of the 
United States. In a cross-sectional analysis of HIV deaths from 2001-2007, nine of the ten states 
with the highest case-fatality rates were located in the southern United States, including 
Tennessee.16 A number of explanations for this disparity exist. A prominent explanation 
concerns the large proportion of rural areas in the South compared to other regions in the United 
States. Comparing HIV testing between urban and rural areas, individuals residing in rural areas 
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were less likely to receive HIV testing, potentially leading to later diagnosis of HIV in rural 
areas.17 Later diagnosis may contribute to the higher rate of mortality. Patients with HIV who 
live in rural areas have higher mortality rates than urban patients with HIV despite similar CD4 
counts at presentation and while controlling for age, sex, race, and HIV risk factors.18 
Demographics of HIV patients are also different in the rural South compared to the urban South. 
For example, South Carolina rural HIV residents were more likely to be black, non-Hispanic, 
and female than urban residents.19 
HIV Treatment 
 Since HIV first surfaced in the United States in the early 1980s, much has changed 
concerning the knowledge of the virus, its risk factors, and treatment. During the early stages of 
the HIV epidemic, infections mostly consisted of white MSM and male IDUs.20 The HIV 
treatment drug Azido-Thymidine (AZT) was first approved by the Food and Drug 
Administration (FDA) in March of 1987.21 An estimated 19.1 million lives between 1990 and 
2013 have been saved.22 
In 1996, highly active antiretroviral therapy (HAART) was implemented and 
dramatically changed the outlook of HIV/AIDS treatment.23 HAART actively controls viral 
loads, delaying the diagnosis of AIDS. Since it has been in use, a diagnosis of HIV has shifted 
from a terminal illness to a manageable condition. The effectiveness of potent medications has 
brought on other new challenges as well. Because HAART needs to be taken daily in order to be 
effective, patients often do not take their medication as advised.24 Some patients also falsely 
believe that using HAART eliminates their risk of transmission and, in turn, may resume unsafe 
sexual practices25 and injection drug use.26 
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 Together, medical advances and HIV awareness have changed the demographics of 
persons diagnosed. Since 2005, researchers have observed an estimated 17% increase of HIV 
diagnoses among MSM.20 Moreover, while HIV infections were generally concentrated in urban 
areas, greater infection has begun to occur among rural populations especially in the South.3  
Populations at Risk 
As previously mentioned, men who have sex with men and intravenous drug users have 
the highest risk for HIV infection. These populations are predominantly males. Women are at 
risk mainly from heterosexual contact with an HIV infected partner. In 2010, 86 percent of 
female infections were attributed to heterosexual transmission.20 Furthermore, HIV among 
women has become more problematic in the South with steadily increasing HIV incidence and 
mortality.27  
 HIV infections disproportionally affect ethnic minorities – notably, African-Americans. 
As of 2010, African-Americans accounted for a higher proportion of HIV infections than any 
other population at all stages from diagnosis to death.20 The majority of these infections have 
occurred in men, but African-American women also had a diagnosis rate 20 times higher than 
white women. Explanations of this inequity vary. One highlights the higher prevalence among 
the African-American community in general and posits that one is more likely to become 
infected simply by choosing a partner within his or her own community.28 Another points out 
that African-Americans are typically diagnosed at later disease stages, which causes them to start 
therapy later than recommended. Finally, African-Americans are more likely to discontinue 
treatment once started.29 
 While gender, sexual orientation, and ethnicity may increase one’s risk to acquire HIV, 
risk also varies by age. Among adolescents and young adults (13-24), 69.5 per 100,000 are 
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infected with HIV, with the majority of incident cases again occurring among African-
Americans (57.4%). Alarmingly, despite the high rate of HIV infection among youth, more than 
half (59.5%) were estimated to be unaware of their infection.30 HIV also disproportionally 
affects youths geographically. Southern youth have significantly higher HIV rates (77.6 per 
100,000) than the nation’s youth overall (69.5 per 100,000).30 The high prevalence of HIV 
among youth may be related to vulnerability of the life stage, as youth are more prone to peer 
pressure, risky sexual behavior, and drug use.20  
 Persons 50 years or older represented 16% of all incidence of HIV diagnosis in the 
United States in 2010,31 an increase since 2000. Some argue that older people – as well as their 
medical providers – may discount their risk for infection and therefore engage in unsafe health 
practices that put them at further risk.20 Alternatively, medication advances have allowed those 
diagnosed with HIV to live longer, well beyond the 5th decade. As of 2014, the over-50 
population made up slightly less than half (42.8%) of all HIV prevalent cases.32  
HIV/HCV Coinfection 
 Compounding the problem for HIV patients is the risk for coinfection with the hepatitis C 
virus (HCV). Like HIV, HCV is a blood borne pathogen, thus sharing HIV transmission routes 
like men who have sex with men33 and intravenous drug use.34 HIV/HCV coinfection has 
typically occurred in large urban areas like New York,34 Chicago, and Los Angeles,33 but a 
number of predominantly rural Appalachian states including Tennessee, Kentucky, Virginia, and 
West Virginia have seen a dramatic increase in HCV.35 Such evidence suggests a high 




 Data indicate that HIV prevention and treatment are improving in the United States, but it 
is not certain if these improvements are consistent across the nation. Rural and remote areas like 
East Tennessee may not show the same benefits of the advancements of medical care and public 
health policies. This thesis aims to describe the characteristics of a largely rural and medically 
underserved population in Tennessee. Furthermore, this project aims to describe the 
epidemiology and risk factors of HIV for the 16 counties that make up the Appalachian region of 
East Tennessee. Lastly, differences in characteristics between counties will be represented 
spatially using geographic information systems (GIS) analysis. Such analyses assist local public 
health officials to prioritize geographic regions and examine trends to gauge improvement and 
better prevent future outbreaks.  
METHODS 
 This study reflects data from the electronic HIV/AIDS Reporting System (eHARS) and 
the National Disease Electronic Surveillance System (NEDSS). All living individuals who 
resided within the 16 county region of East Tennessee and were diagnosed with HIV or AIDS as 
of 2014 were included in the analysis. The 16 counties included Anderson, Blount, Campbell, 
Claiborne, Cocke, Grainger, Hamblen, Jefferson, Knox, Loudon, Monroe, Morgan, Roane, Scott, 
Sevier, and Union. Internal Review Board (IRB) approval was received from the University of 
Tennessee – Knoxville. All data were deidentified prior to analysis.  
Measures 
 Those who had listed “white” as their primary identified ethnicity were categorized as 
such, while the same was done for those who had listed “black.” All other races were identified 
as “other.” Gender was based on the individual’s birth sex. Age of diagnosis was defined as the 
person’s when age he or she received the HIV diagnosis, and current age was defined as the 
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person’s age in December 2015. Initial CD4 counts reflected CD4 counts at the time of 
diagnosis. The first assessed and most recent viral load counts were also used.  
 Insurance attainment was categorized if the patient had any type of medical insurance 
during treatment. Types of insurance included, CHAMPUS, CHIPS, Medicare, Medicaid, private 
insurance, state funded insurance, or VA insurance. Variables for both HIV and AIDS insurance 
were included in the dataset. Any individuals who listed any type of these insurances either for 
HIV, AIDS, or both were categorized as insured.   
  HCV data were extrapolated from the National Disease Electronic Surveillance System 
(NEDSS). HCV cases were correctly matched with the same case in the eHARS dataset prior to 
the analysis. HIV/HCV coinfection cases were identified if an individual had ever received a 
diagnosis for HCV. These included HCV acute confirmed cases, as well as HCV chronic 
confirmed or probable cases. The eHARS and NEDSS data did not include negative HCV testing 
results, nor were all cases tested for HCV, so cases not defined as HIV/HCV positive were 
categorized as unknown.  
 Mode of exposure for HIV infection was classified under 11 different exposure 
categories: MSM, IDU, heterosexual contact (HET), MSM/IDU, IDU/HET, MSM/HET, 
MSM/IDU/HET, Perinatal Transmission, Other, Not Identified, and Not Reported. Clinicians 
associated with the eHARS medical team determined mode of transmission based on self-report, 
patient interviews, and interviews with the patient’s family. Each particular mode of transmission 
was then categorized as its own variable. For example, IDU classification reflected all cases with 
IDU identified either alone or with other transmissions. The same was done for MSM and HET.  
 In order to assess change in HIV risk factors over time, date of diagnosis was categorized 
into three 10 year time periods: (1) 1984-1994, (2) 1995-2004, and (3) 2005-2014. Risk factors 
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were also assessed across the age of diagnosis spectrum. Age of diagnosis was categorized into 
four different age intervals: (1) 12 and younger, (2) 13-24, (3) 25-49, and (4) 50 and older.  
Analysis 
 All quantitative analyses were conducted using SPSS version 22.36 Descriptive analyses, 
including both categorical and continuous variables, were used to describe the population. 
Categorical variables included gender, race, current age, age of diagnosis, HIV/HCV coinfection, 
medical insurance, and mode of exposure. Continuous variables include CD4 counts and both 
initial and most recent viral loads. Chi-squared analyses were conducted in order to assess the 
association of year of diagnosis with gender, race, HIV/HCV coinfection, mode of exposure, and 
MSM, IDU, and HET exposures.  
 Spatial analysis was conducting using ArcGIS 10.3.37 All cases were examined by the 16 
counties of current residence. Intervals of five graduated colors were used to show differing 
frequency, percentage, or rate. Frequencies for the number of HIV cases by county are shown in 
each of the counties. Estimated resident populations as of 2014 for each of the 16 counties were 
pulled from U.S. Census Data.38  Rates of HIV per county were determined based on these 
population statistics and normalized to reflect values per 10,000 people.  
 The stratification of year and age of diagnosis is also represented spatially by county. 
Percentages were determined for both age and year of diagnosis based on the number of persons 
infected with HIV for each county respectively. Percentages were also determined for MSM 
exposure, IDU exposure, HET exposure, race, and gender. Percentages of HIV/HCV coinfection 




 The sample included 1548 cases. Of these, the vast majority were males (N = 1238, 
80.0%) and white (N = 1197, 77.2%). Black individuals made up 315 cases (20.3%), while the 
remaining 30 cases (1.9%) were categorized as other. Eight cases were missing data for race (N 
= 1540). The mean age of diagnosis was 34.6 years (range = 0-79, SD = 10.85), and the mean 
current age was 46.9 (range = 1-85, SD = 11.72). Of the cases, 259 (16.7%) had some type of 
insurance, and 90 cases (5.8%) were positive for HIV/HCV coinfection. The mean CD4 value 
was 15822.6 (N = 1430, range = 0-2360000, SD = 324.3). For viral loads, the first detected viral 
loads mean level was 880886.98 (N = 1333, range = 19-1000000000, SD = 27390768.09), and 
the recent viral load mean level was 15822.6 (N = 1399, range = 0-2360000, SD = 104381.18). 
 Spatial analysis by county (Figure 1) revealed that Knox County had the most cases of 
HIV with 875. Anderson, Blount, and Sevier County all fell within the 58-129 cases category 
and represented the highest frequencies behind Knox County. Knox County also showed the 
highest rate, with 19.5 cases per 10,000 people (Figure 2). Anderson County had the second 
highest rate of 13.1 per 10,000. Most counties (N = 8) had a rate between 7.2-10.2.  
Female HIV rates are spatially represented in Figure 3. Knox County showed the highest 
rate of female HIV diagnoses (7.78 per 10,000), while Anderson, Blount, Cocke, Loudon, and 
Monroe County showed rates of 3.37-5.66 per 10,000. Rates of black HIV diagnoses were 
highest for Morgan County (Figure 4; 124.78 per 10,000). Scott County was the most likely to 
have insurance (66.7%), while Monroe (12.8%) and Morgan (8.3%) were the least likely to be 
insured (Figure 5).  HCV/HIV coinfection was more prevalent in Claiborne (25.0%) and Morgan 
County (16.7%), while Campbell, Loudon, Roane, and Sevier County showed percentages from 
5.9%-11.3% (Figure 6).  
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Year of diagnosis was categorized into three different groups. From 1984 to 1994, 225 
(14.5%) individuals were diagnosed with HIV. Between 1995-2004, 657 (42.4%) individuals 
were diagnosed with HIV, and the remaining 666 (43.0%) cases were diagnosed from 2005 to 
2014. Those diagnosed from the ages of 0 to 12 made up 24 cases (1.6%); 234 (15.1%) cases 
were diagnosed between the ages of 13-24, while 1166 (75.3%) were diagnosed between the 
ages of 25-49. The remaining 123 (8.0%) cases were diagnosed at 50 or older.  
Percent of HIV diagnosis by year of diagnosis was shown in Figure 7. The years between 
1984-1994 show that Anderson, Blount, Grainger, Hamblen, Monroe, Morgan, and Roane 
County had a high rate of their HIV cases occur in this time period, while Union and Cocke 
County had a low rate. With respect to the years between 1995-2004, Cocke, Grainger, Morgan, 
and Roane County showed a high proportion of HIV cases, while Scott County showed a low 
proportion. Lastly, between 2005-2014, counties in the northern part of the region – such as 
Anderson, Campbell, Claiborne, Hamblen, Scott, and Union County – evidenced a high 
proportion of HIV cases. Contrastingly, during the same time frame, Grainger, Morgan, and 
Roane County showed a low proportion of HIV cases.    
Percent of HIV diagnosis by age of diagnosis was shown in Figure 8. Cocke County 
showed the highest percentage of cases occurring between 0-12 (6.3%), while Loudon (4.3%) 
and Monroe (5.1%) showed moderately high percentages. For ages of diagnosis between 13-24, 
Scott County showed the highest percentage (22.2%). All counties had the majority of HIV 
diagnoses occur from ages 25-49. Of these, Claiborne (87.5%) and Roane (84.2%) had the 
highest percentage of cases occurring between 25-49. Campbell (80.0%) and Monroe (79.5%) 
County showed moderately high percentages for this age category. Of those 50 and older, Union 
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County had the highest percentage represented (25.00%). Blount, Campbell, Grainger, and 
Jefferson Counties showed slightly lower percentages (8.75%-17.30%).  
Mode of exposure was spatially represented for each county. Percentages of HIV 
diagnoses by MSM (Figure 9) were most prevalent in Claiborne, Grainger, Hamblen, and Scott 
Counties (67.5%-88.9%), while rates of HIV diagnoses by IDU (Figure 10) were most prevalent 
in Campbell (28.0%) and Morgan County (29.2%). Cocke and Monroe County showed rates of 
those infected by of heterosexual contact (Figure 11; 25.0%-35.9%).  
 Chi-squared analysis revealed that mode of exposure, HIV/HCV coinfection, IDU 
transmission, and heterosexual transmission differed significantly by year of diagnosis (Tables 1-
4). Gender, race, and MSM transmission did not significantly differ by year of diagnosis (Tables 
5-7).  
With respect to mode of exposure (Table 1), the percentage of MSM and HET 
transmission was relatively consistent across the three diagnostic time periods (χ2 = 144.300; df = 
20; p = .000), while the percentage of IDU significantly differed by year of diagnosis from 1995-
2004 (7.6%) to 2005-2014 (2.4%). A significant difference occurred across year of diagnosis for 
mode of exposure not reported, with a higher percentage occurring in the 2005-2014 period 
(13.5%). Percentages of cases for HIV/HCV coinfection have differed by time of diagnosis (χ2 = 
5.985; df = 2; p = .050), with the greatest proportion (9.3%) occurring for those diagnosed in the 
1984-1994 period. In the 2005-2014 period, that percentage decreased to 5.1%.  
IDU transmission differed across year of diagnosis (Table 3), with 19.1% reflected in 
1984-1994 and 14.9% reflected for the 1995-2004 period. Comparably this proportion was 6.5% 
in 2005-2014 (χ2 = 35.721; df = 2; p = .000). Heterosexual transmission showed a different 
pattern than IDU transmission across period of diagnosis (Table 4). Percentages of heterosexual 
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transmission jumped from 17.8% to 23.3% between 1984-1994 and 1995-2004, but were falling 
to 15.8% for the 2005-2014 period (χ2 = 12.405; df = 2; p = .002).  
Chi-squared analysis revealed that mode of transmission, MSM transmission, gender, and 
race significantly varied across age intervals (Tables 8-11). HIV/HCV coinfection, IDU and 
heterosexual transmission did not differ significantly across age intervals (Tables 12-14).  
Perinatal transmission was most prevalent for the 0-12 age group (83.3%), while MSM 
transmission was most prevalent for persons 13 and older (45.2%-57.8%) (Table 8; χ2 = 
1275.929; df =30; p = .000). IDU was most prominent in the 25-49 group (6.1%), and 
heterosexual transmission is most prominent in the 13-24 group (16.2%). Cases not reported 
differed by age, with higher percentages occurring with increased age. For cases of MSM 
transmission (Table 9), with or without IDU or heterosexual transmission, the most prevalence 
was among the 13-24 (62.4%) and 25-49 (62.8%) age groups (χ2 = 47.73; df = 3; p = .000). 
Prevalence was lower than average for persons diagnosed 50+ (48.4%).  
The proportion of females differed with age of diagnosis (Table10; χ2 = 27.784; df =3; p 
= .000). Of those diagnosed between the ages of 0-12, 50.0% were females. That percentage was 
25.2% for those diagnosed between 13-24, but this group also showed the highest percentage of 
females infected at 13 and older. For those diagnosed between 25-49 and 50+, the percentages 
were 18.4% and 19.4% respectively. Race varied by age (Table 11), as the percentage of whites 
differed with age of diagnosis (χ2 = 19.861; df =6; p = .003). Whites had the greater 
representation for the older HIV cases (82.1%). The majority of HIV cases were diagnosed from 




The study results characterize the prevalent HIV cases of East Tennessee, as well as how 
these characteristics differed by age and period of diagnosis. Results also show how these 
characteristics differ by county of residence. These analyses provide critical support to better 
understand HIV in the South, where HIV cases disproportionally occur.3,4,5 Moreover, the 
demographics of East Tennessee very much resemble demographics of areas with recent HIV 
outbreaks.15,19 These findings can potentially help prevent future HIV outbreaks.  
Demographic Differences 
 Persons diagnosed with HIV in this 16 county region in East Tennessee were 
significantly more likely to be white (77.2%) than the state of Tennessee as a whole (31.0%). 
This is in keeping with the demographics of East Tennessee. For example, Knox County – the 
region’s most diverse county – is still 86.3% white.38 This is nearly 10% higher than the 
statewide percentage of white individuals (78.9%).38  However, the percentage of white 
diagnoses did not correlate with the percentage of white population in each county. Morgan 
County, with only 3.7% of its population listed as black,38 had the highest rate of black HIV 
diagnoses (124.78 per 10,000) for this region. Although whites made up the majority of those 
living with HIV in East Tennessee, blacks still had higher rates of HIV, which is similar to the 
current literature.20 
 Insurance coverage was also very low in this population. Only 16.7% of HIV cases 
reported insurance.  This percentage of insured patients is particularly concerning give the 
implementation of the Affordable Care Act. While Tennessee chose not to expand Medicaid, this 
percentage is still lower than necessary for those managing a chronic disease.  
Compared to the state as a whole (2.9%),6 this 16 county region displayed a higher 
proportion of HIV diagnoses transmitted associated with IDU (11.9%). This disparity may be 
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attributed to the higher number of intravenous drug users in Appalachia compared to the state as 
a whole, as Tennessee ranks second among all fifty states for prescription opioids – which can be 
crushed and administered intravenously – per capita (143 per 100).15 Interestingly, some of the 
more rural counties (e.g., Campbell, Morgan) evidenced a greater percentage of HIV infection by 
IDU than more urban counties. Rural counties also displayed a high proportion of HCV/HIV 
coinfection, supporting the suggested link between IDU and HCV.34  
Changes across Time 
 Through the three diagnosis periods, the number of IDUs, HETs, and HCV/HIV 
coinfection have changed. In the case of IDU, the fewer cases of HIV transmitted by IDU 
mirrors that of the national data.20 This difference in IDU transmission may correlate with the 
decrease in HCV/HIV coinfection. IDU is the primary mode of transmission,34 and 20.7% of all 
those diagnosed with HIV by IDU in the sample were coinfected with HCV compared to the 
3.8% of those coinfected that were not IDUs. IDU decrease has been attributed to the increase in 
syringe exchange programs and substance abuse treatment. However, Tennessee does not offer 
syringe exchange programs at the state level. In fact, there is only one syringe exchange program 
in the state located Nashville, which is not in the 16 county region of this study.39 Nevertheless, 
residence reflects current location, so persons could have been diagnosed elsewhere – such as a 
location with syringe exchange programs – and then migrated to this 16 county region. It is alos 
possible that person who contract HIV via IDU may be less compliant with their medication and 
thus have a greater mortality risk.  Only people who are living with HIV or AIDS are included in 
these data.  Finally, the number of cases not reported is highest for the 2005-2014 period, which 
may also attribute to the low percentage of IDU transmission during this time.  
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 MSM, IDU, and HET transmission were reflected in the greatest number of cases in the 
1995-2004 diagnosis period. This is perhaps due the high number of total HIV diagnoses for this 
time frame. While rates for HIV diagnoses decreased dramatically for later decades, the 
percentage reflecting MSM and HET transmission only slightly decreased. Perhaps efforts to 
decrease IDU diagnoses – like substitution therapy and awareness programs – have been 
successful throughout the region. Moreover, further efforts for HIV prevention should be 
concentrate on sexual health.  
 The percentage of cases whose transmission was not reported differs across the three 
diagnosis periods, with higher percentages occurring in the 2005-2014 period. Clinicians may 
possibly need time to determine the correct modes of transmission. For these cases, the mode of 
transmission may be updated if the patient becomes more comfortable with disclosure.   
Changes across Age of Diagnosis 
 Mode of transmission, MSM transmission, gender, and race significantly differed by age 
of diagnosis. All modes of transmission showed highest percentages among the 25-49 age group. 
For MSM, this may reflect an increased comfort of homosexual acts with age. Individuals who 
engage in this type of behavior may not feel comfortable doing so until a later age due to 
negative societal pressure. Persons within the 25-49 age group may also be more accepting of 
gay rights, and therefore more comfortable reporting this experience, than older individuals. 
Comfort of sexual behavior may increase in general, leading to increases in heterosexual 
transmission. For IDUs, substance use may start in age group 13-24 more generally, with 
substances like marijuana and alcohol.40 Transition to substances that are administered 
intravenously may not occur until age 25, accounting for the high number of IDUs diagnosed 
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with HIV in this age group. The 25-49 group also is a large age range, which contributes to the 
greater number of cases in this group compared to the remaining three smaller age populations.  
 The percentages of females diagnosed with HIV changed with age of diagnosis. The 
distribution was equal ages 0-12, where the majority of case (83.0%) occurred via perinatal 
transmission. The inequity of diagnoses between males and females reflects the gender exclusive 
transmission by MSM. Concerning race, all races were more likely to be diagnosed between ages 
25-49. Blacks accounted for 25.8% of all HIV diagnoses between 13-24 in this study, and this 
percentage is smaller with increasing age of diagnosis. Individuals diagnosed in the 13-24 age 
group are more likely to receive TennCare than their older counterparts,41 increasing their 
likelihood of treating and living with HIV. Persons who have died after an HIV diagnoses are not 
included in the study, which may account for the low percentages among older blacks as they are 
less likely to receive treatment.29 
The percentage of cases not reported differed by the age of diagnosis cohort. Persons 50 
and older showed a significantly higher percentage of cases not reported. Such results could stem 
from older individuals being harder to reach in terms of data collection. Moreover, the older 
individuals may also feel more stigmatized based on their HIV diagnosis and be reluctant to 
speak with clinicians attempting to determine the mode of transmission compared to younger 
people.  
County Disparity 
 Knox County may benefit most through prevention efforts as this county has both the 
highest frequency and rate of HIV diagnosis. However, because the sample is limited to 
prevalence data, this could also mean that Knox County provides better care for those diagnosed 
with HIV than the surrounding counties. This would not only extend the survival period, but 
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those diagnosed with HIV in a surrounding county may move to Knox County after learning of 
their diagnosis. Urban areas typically provide better access to treatment facilities without the 
need of traveling long distances.  
 Most counties saw the greatest percentage of surviving HIV cases being diagnosed from 
1995-2004. However, northern counties such as Anderson, Campbell, Claiborne, Hamblen, 
Scott, and Union County saw high percentages occurring from 2005-2014. This could suggest 
that HIV is beginning to spread into more rural areas. Furthermore, this could also mean that 
persons diagnosed with HIV in these counties have greater mortality rates due to more 
challenging healthcare access. Because persons diagnosed with HIV who are deceased are not 
included in the sample, this could account for low percentages from 1984-2004.  Those 
diagnosed earlier may also have moved to more urban counties to receive care as their HIV 
progresses.  
 Overall, these analyses also aid in prevention measures for each of the 16 counties. Local 
public health departments can see which variables are highest in their respective population and 
use them for more effective prevention efforts. For example, Campbell, Loudon, Morgan, and 
Sevier County showed the high percentages of HIV diagnoses by IDU, so prevention efforts 
among these populations may be more effective if they are focused on substance use. Among 
these, Campbell, Loudon, and Morgan all showed a higher percentage of HCV coinfection 
among those diagnosed with HIV. Thus, prevention efforts may double for both HIV and HCV.  
 Percentages of MSM transmission were highest in Claiborne, Grainger, Hamblen, and 
Scott County (67.51%-88.89%). These are primarily rural areas, where MSM is more likely to be 
stigmatized. Residents may be reluctant to discuss their sexual health, and even use sexual 
behavior to cope with discrimination.10,11 Rates of female diagnoses by county roughly 
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correspond to percentages of HIV by HET transmission per county. Counties with both high 
rates of female and high percentages of HIV diagnoses by HET include Anderson, Cocke, Knox, 
and Monroe. This is similar to the national population, where 86% of HIV transmission among 
females occurs via HET transmission.20 Rates of black diagnoses were highest in Morgan 
County despite having a low black population (3.7% of 21,987).  
LIMITATIONS 
 Despite these findings, this study has limitations. First, the data reflect only prevalent 
cases, which are valuable in order to understand the characteristics of the current population. 
Those diagnosed in the early years of HIV infection (i.e., 1980s) are more likely to have died due 
to the infection and are not included in the sample. This may skew results for modes of 
transmission like IDU. IDUs are less likely to receive HAART treatment than non-IDUs,20 
which would also decrease the representation of IDUs within the sample. Although the 
percentage of HIV transmitted by IDU in this sample (11.9%) are higher than the state average 
(2.9%), this could be higher if all deceased cases were included within the sample.  
Mode of transmission was determined based on self-report, patient interviews, and family 
interviews, which yields the possibility for error. This is likely reflected in the Not Identified and 
No Reported Risk categories that show higher percentages with higher age. Such a limitation 
does not allow the study to provide a full picture of the characteristics of current cases in the east 
region. 
 The modifiable areal unit problem (MAUP) is a statistical bias that affects the validity of 
GIS data in this sample. This stems from the idea that the data are aggregated into counties based 
on current address. These addresses can be modified, so an individual that currently resides in a 
certain county may have contracted HIV in another county. Moreover, individuals residing in a 
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certain county may not be an exact reflection of that county. He or she may live on the border 
and use the better resources of the neighboring county rather than the one in which he or she 
currently resides. Facilities in neighboring counties may also be closer than ones in the 
individual’s current county of residence. Individuals can cross county boundaries as well, 
perhaps sharing needles residents from different counties or connecting with sexual partners 
residing in a different county.  
FUTURE RESEARCH 
 Research is necessary to decrease the risk of HIV epidemics like those in and South 
Carolina3 and Indiana.14 These predominantly poor, rural, and white demographics are quite 
similar to the one included in this sample and suggest that the 16 county region of East 
Tennessee could be at an equal risk. Furthermore, Appalachian regions such as this one have 
shown recent high rates of HCV.35 However, while recent work has been done on strictly HCV 
in Appalachia, no work has been done for HCV/HIV coinfection in this region. Because those 
diagnosed with HIV are at an increased risk for HCV,34 and HCV rates are currently high in the 
region, it is important that examination of HIV/HCV coinfection be done. Lastly, future work 
should examine if the rate of insurance increases with the Affordable Care Act.  
CONCLUSION 
 While HIV is now a treatable disease, those in the rural South seem to be 
disproportionally affected.5 Recent outbreaks in largely poor, rural, and heavily white 
concentrated areas have caused concern for similar areas in the U.S. Of these, East Tennessee 
has demographics that resemble those that have seen recent outbreaks. Using eHARS prevalence 
data, results showed that those infected by HIV in East Tennessee are predominantly white and 
male. The majority of cases occurred among those diagnosed from ages 25-49 and in the 1995-
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2004 diagnosis period. Targeting would be most effective among the 25-49 population, since it 
showed to be the predominant age of diagnosis. Insurance rates were quite low, which is 
alarming even with the lack of complete data. Only 16.7% of those claimed insurance coverage, 
despite the implementation of the Affordable Care Act.   
The majority of cases occurred via MSM transmission, but the percentage of those 
infected by IDU transmission is higher than the state of Tennessee as a whole. Rates among 
blacks showed disproportionately high rates in some counties. Screening should be utilized by 
public health departments based on rates of certain variables (i.e., African-Americans, IDUs) for 
each county. Knox County had both the highest frequency and rate of HIV diagnoses of the 16 
counties, which implies that focused prevention could be effective here but that this county has a 
lower mortality rate than surrounding counties. Funding for HIV treatment in Knox County, as 
well as counties with high HIV prevalence rates should be provided due to the number of people 
seeking medical care. Future research should continue to examine statistics of this population in 
order to design more effective prevention efforts. Because rates of HCV coinfection have also 
shown to be high in the region, the potential for increasing rates of HCV/HIV coinfection is 
possible. Further efforts should be made both to collect HCV/HIV coinfection data, and also to 
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χ2 = 144.300; df = 20; p = .000 
 
Table 2 
HCV by Year of Diagnosis  
(N = 1548) 
 No HCV Diagnosis HCV Diagnosis 
1984-1994 204 (90.7%) 21 (9.3%) 
1995-2004 622 (94.7%) 35 (5.3%) 
2005-2014 632 (94.9%) 34 (5.1%) 
Total 1458 (94.2%) 90 (5.8%) 
χ2 = 5.985; df = 2; p = .050 
 
Table 3 
IDU by Year of Diagnosis  
(N = 1548) 
 No IDU IDU 
1984-1994 182 (80.9%) 43 (19.1%) 
1995-2004 559 (85.1%) 98 (14.9%) 
2005-2014 623 (93.5%) 43 (6.5%) 
Total 1365 184 (11.9%) 














Heterosexual Transmission by Year of Diagnosis  
(N = 1548) 
 No HET HET 
1984-1994 185 (82.2%) 40 (17.8%) 
1995-2004 504 (76.7%) 153 (23.3%) 
2005-2014 561 (84.2%) 105 (15.8%) 
Total 1250 (80.7%) 298 (19.3%) 
χ2 = 12.405; df = 2; p = .002 
 
Table 5 
Gender by Year of Diagnosis 
(N = 1548) 
 Female Male 
1984-1994 36 (16.0%) 189 (84.0%) 
1995-2004 144 (21.9%) 513 (78.1%) 
2005-2014 130 (19.5%) 536 (80.5%) 
Total 310 (20.0%) 1238 (80.0%) 
χ2 = 3.852; df = 2; p = .146 
 
Table 6 
Race by Year of Diagnosis  
(N = 1540) 
 White Black Other 
1984-1994 173 (77.9%) 47 (21.1%) 2 (0.9%) 
1995-2004 509 (78.1%) 134 (20.6%) 9 (1.4%) 
2005-2014 513 (77.0%) 134 (20.1%) 19 (2.9%) 
Total 1195 (77.6%) 315 (20.5%) 30 (1.9%) 
χ2 = 5.272; df = 4; p = .261 
 
Table 7 
MSM by Year of Diagnosis  
(N = 1548) 
 No MSM MSM 
1984-1994 77 (34.2%) 148 (65.8%) 
1995-2004 269 (40.9%) 388 (59.1%) 
2005-2014 264 (39.6%) 402 (60.4%) 
Total 610 (39.4%) 938 (60.6%) 











Type of Exposure by Age of Diagnosis  
(N = 1548) 
Exposure Category 



























































































































χ2 = 1275.929; df =30; p = .000 
 
Table 9 
MSM by Age of Diagnosis  
(N = 1548) 
 No MSM MSM 
0-12 24 (100.0%) 0 (0.0%) 
13-24 88 (37.6%) 146 (62.4%) 
24-49 434 (37.2%) 732 (62.8%) 
50+ 64 (51.6%) 60 (48.4%) 
Total 610 (39.4%) 938 (60.6%) 
χ2 = 47.291; df = 3; p = .000 
 
Table 10 
Gender by Age of Diagnosis  
(N = 1548) 
 Female Male 
0-12 12 (50.0%) 12 (50.0%) 
13-24 59 (25.2%) 175 (74.8%) 
25-49 215 (18.4%) 951 (81.6%) 
50+ 24 (19.4%) 100 (80.6%) 
Total 310 (20.0%) 1238 (80.0%) 












Race by Age of Diagnosis  
(N = 1540) 
 White Black Other 
0-12 16 (66.7%) 8 (33.3%) 0 (0.0%) 
13-24 164 (70.4%) 60 (25.8%) 9 (3.9%) 
25-49 914 (78.8%) 226 (19.5%) 20 (1.7%) 
50+ 101 (82.1%) 21 (17.1%) 1 (0.8%) 
Total 1195 (77.6%) 315 (20.5%) 30 (1.9%) 
χ2 = 14.797; df =6; p = .022 
 
Table 12 
HCV by Age of Diagnosis  
(N = 1548) 
 No HCV Diagnosis HCV Diagnosis 
0-12 22 (91.7%) 2 (8.3%) 
13-24 244 (95.7%) 10 (4.3%) 
25-49 1096 (94.0%) 70 (6.0%) 
50+ 116 (93.5%) 8 (6.5%) 
Total 1458 (94.2%) 90 (5.8%) 
χ2 = 1.461; df =3; p = .691 
 
Table 13 
IDU by Age of Diagnosis  
(N = 1548) 
 No IDU IDU 
0-12 24 (100.0%) 0 (0.0%) 
13-24 208 (88.9%) 26 (11.1%) 
25-49 1019 (87.4%) 147 (12.6%) 
50+ 113 (91.1%) 11 (8.9%) 
Total 1365 (88.1%) 184 (11.9%) 
χ2 = 5.027; df = 3; p = .170 
 
Table 14 
Heterosexual Transmission by Age of Diagnosis  
(N = 1548) 
 No HET HET 
0-12 24 (100.0%) 0 (0.0%) 
13-24 184 (78.6%) 50 (21.4%) 
25-49 942 (80.8%) 224 (19.2%) 
50+ 100 (80.6%) 24 (19.4%) 
Total 1250 (80.7%) 298 (19.3%) 
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